Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Pharmaceutical industry in China Stories

2012-08-23 02:25:51

DALLAS, August 23, 2012 /PRNewswire/ -- According to a new market research report "World Sensors Market in Healthcare Applications (2012-2017), Global Forecast & Analysis - Segmentation by Type of Sensor (Temperature, Pressure, Chemical, Flow, Level, Position, Image and Biosensors), Monitoring, Therapeutic, Diagnostic, Drug Discovery & Delivery Applications, Geographical & Country-wise Markets" published by MarketsandMarkets (http://www.marketsandmarkets.com), the...

2012-08-23 02:25:43

REDWOOD CITY, Calif., Aug. 23, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the following investor conferences: 2012 Southern California Investor ConferenceDate: Thursday, August 30, 2012 at 1:30 p.m. PDT (4:30 p.m....

2012-08-22 06:24:20

PARSIPPANY, N.J. and MUMBAI, India, Aug. 22, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received tentative US FDA approval for marketing a generic version of 20mg, 40mg, 60mg & 80mg capsules containing Ziprasidone hydrochloride, which is used in the treatment of bipolar disorders and schizophrenia. Ziprasidone capsule is the generic name for the brand Geodon(®), marketed in the US by Pfizer. Wockhardt will launch the product on Sept 02, 2012. (Logo:...

2012-08-22 02:23:30

SHANGHAI, Aug. 22, 2012 /PRNewswire-Asia/ -- Pharma Manufacturing & Quality Management China 2012, organized by CPhI Conferences, will be held on 6th - 7th November in Suzhou, China. China's New GMP Regulation has come into force on 1st March, 2011. There are only 154 out of 5000 pharmaceutical companies in China which passed the new GMP inspection by the end of 2011. Manufacturing sterile drug products such as blood products, vaccines and other injectable drug products will be...

2012-08-22 02:21:53

NEW YORK, Aug. 22, 2012 /PRNewswire/ -- Pharmspective, LLC, a market research firm providing syndicated research and knowledge management applications to the pharmaceutical industry, today announced the release of its research report: State Exchanges: Opportunities and Threats for Key Health Insurers/Implications for Pharmaceutical Manufacturers: http://www.pharmspective.com/healthcare-reform-state-exchanges/.This assessment is a first-of-its kind look into the likely market dynamics...

2012-08-21 14:21:05

MOUNTAIN VIEW, Calif., Aug. 21, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company has received its EU Certificate of GMP Compliance of a Manufacturer. In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia Espanola de Medicamentos y Productos Sanitarios. Based upon the outcome from this inspection of the company's Mountain View, CA facility and additional Company responses, the Spanish authorities, on behalf of the...

2012-08-21 10:24:19

POINT RICHMOND, Calif., Aug. 21, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the U.S. Food and Drug Administration has listed U.S. Patent No. 8,242,131 (the '131 patent) in its Approved Drug Products with Therapeutic Equivalence Evaluations, or "Orange Book." This patent, which was issued by the United States Patent and Trademark Office (USPTO) on August 14, 2012, includes claims directed to methods of treating middle-of-the-night insomnia with low...

2012-08-21 10:23:47

PARSIPPANY, N.J. and MUMBAI, India, Aug. 21, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension. Felodipine is the generic name for the brand Plendil(®), marketed in the United States by Astra Zeneca. Wockhardt is launching the product immediately. (Logo:...

2012-08-21 02:26:56

ORLANDO, Fla., Aug. 21, 2012 /PRNewswire/ -- Nephron Pharmaceuticals Corporation (Nephron) is proud to announce Asthmanefrin, a fast acting, safe and effective over-the-counter (OTC) alternative to the discontinued Primatene® Mist chlorofluorocarbon (CFC) inhaler. Asthmanefrin will provide relief for millions of former Primatene® Mist users. The Primatene® Mist CFC inhaler was removed from the market by the Food and Drug Administration (FDA) and the Environmental Protection...

2012-08-20 10:24:43

MOUNTAIN VIEW, Calif., Aug. 20, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company will participate in the Stifel Nicolaus 2012 Healthcare Conference, being held in Boston, MA, on September 5 - 6, 2012. The Alexza corporate presentation will be Wednesday, September 5, 2012 at 1:30 p.m. Eastern Time. The presentation will be webcast live. To access the presentation via the Web, please go to the Alexza Investor Relations tab at www.alexza.com or...